Acorda Therapeutics Inc:
* Christopher M. James reports a 5.9 percent passive stake in Acorda Therapeutics Inc as of June 27, 2017- sec filing Source text (bit.ly/2tz6Pgg) Further company coverage:
July 7th, 2017 | 16:10 PM healthcare 296
Acorda Therapeutics Inc:
* Christopher M. James reports a 5.9 percent passive stake in Acorda Therapeutics Inc as of June 27, 2017- sec filing Source text (bit.ly/2tz6Pgg) Further company coverage: